IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating
Company: Novavax, Inc.
Symbol: NVAX
Price: Last trade $9.26
Trade Date: 3/26
Shares: 18.9 million
Underwriter(s) J.P. Morgan, Citigroup
Rating=Subscription Needed
Company: Nationstar Mortgage Holdings Inc.
Symbol: NSM
Price: Last trade $31.14
Trade Date: 3/25
Shares: 17.5 million
Underwriter(s) Citigroup, Barclays, J.P. Morgan
Rating=Subscription Needed
Company: EnLink Midstream
Symbol: ENLK
Price: Last trade $26.92
Trade Date: 3/25
Shares: 22.8 million
Underwriter(s) Morgan Stanley, Wells Fargo, Barclays, BofA Merrill Lynch, J.P. Morgan, UBS Investment Bank, Citigroup, Credit Suisse, Deutsche Bank Securities, Goldman Sachs, RBC Capital Markets, Jeffereis, Raymond James
Co Manager(s) Baird, Oppenheimer & Co.
Rating=Subscription Needed
Company: Air Methods Corp.-BLOCK
Symbol: AIRM
Price: Last trade $48.53
Trade Date: 3/25
Shares: 2 million
Underwriter(s) Credit Suisse
Rating=Subscription Needed